PL2475649T3 - Pochodna indenonu i zawierająca ją kompozycja farmaceutyczna - Google Patents
Pochodna indenonu i zawierająca ją kompozycja farmaceutycznaInfo
- Publication number
- PL2475649T3 PL2475649T3 PL09849272T PL09849272T PL2475649T3 PL 2475649 T3 PL2475649 T3 PL 2475649T3 PL 09849272 T PL09849272 T PL 09849272T PL 09849272 T PL09849272 T PL 09849272T PL 2475649 T3 PL2475649 T3 PL 2475649T3
- Authority
- PL
- Poland
- Prior art keywords
- same
- pharmaceutical composition
- indenone derivative
- indenone
- derivative
- Prior art date
Links
- SNWQUNCRDLUDEX-UHFFFAOYSA-N inden-1-one Chemical class C1=CC=C2C(=O)C=CC2=C1 SNWQUNCRDLUDEX-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
- C07D265/33—Two oxygen atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020090085954A KR101149529B1 (ko) | 2009-09-11 | 2009-09-11 | 인덴온 유도체 및 이를 포함하는 약학적 조성물 |
| PCT/KR2009/006085 WO2011030955A1 (en) | 2009-09-11 | 2009-10-21 | Indenone derivative and pharmaceutical composition comprising same |
| EP09849272.1A EP2475649B1 (en) | 2009-09-11 | 2009-10-21 | Indenone derivative and pharmaceutical composition comprising same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2475649T3 true PL2475649T3 (pl) | 2015-02-27 |
Family
ID=43732606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09849272T PL2475649T3 (pl) | 2009-09-11 | 2009-10-21 | Pochodna indenonu i zawierająca ją kompozycja farmaceutyczna |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8877747B2 (pl) |
| EP (1) | EP2475649B1 (pl) |
| JP (1) | JP5705856B2 (pl) |
| KR (1) | KR101149529B1 (pl) |
| CN (1) | CN102482236B (pl) |
| AU (1) | AU2009352393B2 (pl) |
| BR (1) | BR112012005402B1 (pl) |
| CA (1) | CA2771799C (pl) |
| CL (1) | CL2012000609A1 (pl) |
| CO (1) | CO6511222A2 (pl) |
| DK (1) | DK2475649T3 (pl) |
| EA (1) | EA021353B1 (pl) |
| ES (1) | ES2521517T3 (pl) |
| IL (1) | IL218232A (pl) |
| MX (1) | MX2012002785A (pl) |
| MY (1) | MY164864A (pl) |
| NZ (1) | NZ598394A (pl) |
| PL (1) | PL2475649T3 (pl) |
| PT (1) | PT2475649E (pl) |
| SG (1) | SG178975A1 (pl) |
| WO (1) | WO2011030955A1 (pl) |
| ZA (1) | ZA201201727B (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3135656T (lt) | 2011-06-20 | 2019-04-25 | H. Lundbeck A/S | Deuterinti 1-piperazin-3-fenilindanai, skirti šizofrenijos gydymui |
| US20150148292A1 (en) | 2012-07-09 | 2015-05-28 | Emory University | Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto |
| AR094054A1 (es) * | 2012-12-19 | 2015-07-08 | H Lundbeck As | 6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma |
| CN104370795B (zh) * | 2014-10-15 | 2016-09-28 | 复旦大学 | 一种双靶向卵巢癌细胞微管蛋白及其周围血管的茚酮化合物及其制备方法与应用 |
| CN105585566B (zh) * | 2016-03-09 | 2017-12-29 | 河南师范大学 | 一种茚酮并咪唑并吡啶类化合物的合成方法 |
| WO2017172368A1 (en) | 2016-03-31 | 2017-10-05 | Oncternal Therapeutics, Inc. | Indoline analogs and uses thereof |
| CN106117216B (zh) * | 2016-08-26 | 2019-01-01 | 河南师范大学 | 一种常压合成6H-异吲哚[2,1-a]吲哚-6-酮类化合物的方法 |
| KR101855087B1 (ko) * | 2016-09-27 | 2018-05-04 | 충남대학교산학협력단 | 칼콘 유도체 화합물, 이의 광학이성질체, 또는 이의 약학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 미토콘드리아의 산소 소모율 감소에 의해 야기되는 질환의 예방 또는 치료용 약학 조성물 |
| KR101959636B1 (ko) * | 2017-10-25 | 2019-07-04 | 경북대학교 산학협력단 | 인데엔 화합물을 유효성분으로 함유하는 골 재생 및 골 질환 예방 또는 치료용 조성물 |
| CN107964009A (zh) * | 2018-01-21 | 2018-04-27 | 吕迎春 | 一种2-吡啶衍生物取代的咪唑类化合物及其在防治骨质疏松药物中的应用 |
| CN107892687B (zh) * | 2018-01-21 | 2018-08-24 | 广东莱恩医药研究院有限公司 | 一种2-乙酸酯咪唑类化合物及其在防治骨质疏松药物中的应用 |
| CN113056457B (zh) | 2018-12-03 | 2025-06-20 | H.隆德贝克有限公司 | 用于治疗cns疾病的前药 |
| AU2023299045B2 (en) * | 2022-06-29 | 2026-08-13 | Amyloid Solution Inc. | Novel indenone derivatives and uses thereof |
| CN119301119A (zh) * | 2022-06-29 | 2025-01-10 | 淀粉样蛋白解决方案株式会社 | 新型茚酮衍生物及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3046719C2 (de) | 1980-12-11 | 1983-02-17 | Klinge Pharma GmbH, 8000 München | 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel |
| GB9418067D0 (en) | 1994-09-07 | 1994-10-26 | Orion Yhtymae Oy | Triphenylethylenes for the prevention and treatment of osteoporosis |
| UA51676C2 (uk) | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
| FR2757520B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent |
| AUPR283801A0 (en) | 2001-02-01 | 2001-03-01 | Australian National University, The | Chemical compounds and methods |
| US6903238B2 (en) | 2001-12-13 | 2005-06-07 | Wyeth | Substituted indenones as estrogenic agents |
| KR100592805B1 (ko) * | 2004-04-13 | 2006-06-26 | 한국화학연구원 | 인덴 유도체 및 이의 제조방법 |
| KR100595963B1 (ko) * | 2004-04-13 | 2006-07-05 | 한국화학연구원 | 인덴 유도체 및 이의 제조방법 |
| CN100371325C (zh) * | 2004-07-23 | 2008-02-27 | 中国科学院上海药物研究所 | 一类茚并吲哚酮类化合物、其制备方法和用途 |
| US9185909B2 (en) * | 2007-09-17 | 2015-11-17 | The Trustees Of Columbia University In The City Of New York | Synthesis of resveratrol-based natural products |
-
2009
- 2009-09-11 KR KR1020090085954A patent/KR101149529B1/ko not_active Expired - Fee Related
- 2009-10-21 CN CN200980161354.1A patent/CN102482236B/zh active Active
- 2009-10-21 WO PCT/KR2009/006085 patent/WO2011030955A1/en not_active Ceased
- 2009-10-21 ES ES09849272.1T patent/ES2521517T3/es active Active
- 2009-10-21 BR BR112012005402-3A patent/BR112012005402B1/pt active IP Right Grant
- 2009-10-21 US US13/394,102 patent/US8877747B2/en active Active
- 2009-10-21 CA CA2771799A patent/CA2771799C/en active Active
- 2009-10-21 AU AU2009352393A patent/AU2009352393B2/en not_active Ceased
- 2009-10-21 JP JP2012528724A patent/JP5705856B2/ja not_active Expired - Fee Related
- 2009-10-21 EA EA201270410A patent/EA021353B1/ru not_active IP Right Cessation
- 2009-10-21 MX MX2012002785A patent/MX2012002785A/es active IP Right Grant
- 2009-10-21 SG SG2012015194A patent/SG178975A1/en unknown
- 2009-10-21 NZ NZ598394A patent/NZ598394A/xx unknown
- 2009-10-21 PT PT98492721T patent/PT2475649E/pt unknown
- 2009-10-21 PL PL09849272T patent/PL2475649T3/pl unknown
- 2009-10-21 DK DK09849272.1T patent/DK2475649T3/da active
- 2009-10-21 MY MYPI2012001080A patent/MY164864A/en unknown
- 2009-10-21 EP EP09849272.1A patent/EP2475649B1/en active Active
-
2012
- 2012-02-20 IL IL218232A patent/IL218232A/en active IP Right Grant
- 2012-03-07 CL CL2012000609A patent/CL2012000609A1/es unknown
- 2012-03-09 ZA ZA2012/01727A patent/ZA201201727B/en unknown
- 2012-03-09 CO CO12041482A patent/CO6511222A2/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012005402B1 (pt) | 2022-05-31 |
| US20120214991A1 (en) | 2012-08-23 |
| MY164864A (en) | 2018-01-30 |
| BR112012005402A2 (pt) | 2020-10-06 |
| CO6511222A2 (es) | 2012-08-31 |
| KR20110028050A (ko) | 2011-03-17 |
| JP5705856B2 (ja) | 2015-04-22 |
| EP2475649B1 (en) | 2014-08-13 |
| WO2011030955A1 (en) | 2011-03-17 |
| IL218232A (en) | 2015-11-30 |
| MX2012002785A (es) | 2012-04-11 |
| AU2009352393A1 (en) | 2012-03-22 |
| CN102482236A (zh) | 2012-05-30 |
| DK2475649T3 (da) | 2014-11-03 |
| CN102482236B (zh) | 2015-01-28 |
| EP2475649A4 (en) | 2013-02-13 |
| ZA201201727B (en) | 2012-11-28 |
| CA2771799A1 (en) | 2011-03-17 |
| HK1166633A1 (en) | 2012-11-02 |
| NZ598394A (en) | 2013-07-26 |
| AU2009352393B2 (en) | 2015-12-24 |
| EA201270410A1 (ru) | 2012-08-30 |
| CL2012000609A1 (es) | 2012-09-14 |
| SG178975A1 (en) | 2012-04-27 |
| JP2013504566A (ja) | 2013-02-07 |
| PT2475649E (pt) | 2014-10-15 |
| KR101149529B1 (ko) | 2012-05-25 |
| EA021353B1 (ru) | 2015-05-29 |
| EP2475649A1 (en) | 2012-07-18 |
| US8877747B2 (en) | 2014-11-04 |
| CA2771799C (en) | 2016-11-08 |
| ES2521517T3 (es) | 2014-11-12 |
| IL218232A0 (en) | 2012-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275854A (en) | Pharmaceutical composition and its administration | |
| ZA201201727B (en) | Indenone derivative and pharmaceutical composition comprising same | |
| IL217912A (en) | History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It | |
| IL242883B (en) | Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them | |
| ZA201200722B (en) | Pharmaceutical composition and administrations thereof | |
| SG175037A1 (en) | Pharmaceutical composition | |
| IL214911A0 (en) | Solfonylated tetrahydroazolopyrazines and their use as medicinal products | |
| ZA201106162B (en) | Solid pharmaceutical composition comprising amlodipine and losartan | |
| ZA201107022B (en) | Drug fusions and conjugates | |
| IL206594A (en) | The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations | |
| IL215497A0 (en) | Oxadiazile derivatives and pharmaceutical compositions containing them | |
| EP2379077A4 (en) | PHARMACEUTICAL COMPOSITION | |
| IL216006A0 (en) | Substituted aromatic compounds and pharmaceutical uses thereof | |
| SI2229940T1 (sl) | Farmacevtski sestavek s protivnetnimi in antihistaminskimi lastnostmi | |
| ZA201200079B (en) | Pharmaceutical compositions and solid forms | |
| EP2445895A4 (en) | PIPERAZINE THITHIOCTATE AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| PT2474306T (pt) | Composição particulada e composição medicinal que a compreende | |
| PT2597084T (pt) | Derivado de n-hidroxiformamida e medicamento contendo o mesmo | |
| PL2484661T3 (pl) | Pochodna 2,3-dihydro-1h-inden-2-ylomocznika i jej zastosowanie farmaceutyczne | |
| PL2298090T3 (pl) | Kompozycja farmaceutyczna lub nutraceutyczna | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| GB0919650D0 (en) | Pharmaceutical composition | |
| GB0908069D0 (en) | Pharmaceutical compounds and compositions | |
| GB0919055D0 (en) | Pharmaceutical compounds and compositions |